Research
Ten-Year Review of Ketamine Psychedelic Therapy (KPT) for Alcoholism Treatment
This comprehensive review, published in the Journal of Psychoactive Drugs, encapsulates a decade of research on Ketamine Psychedelic Therapy (KPT). The study delves into the use of ketamine, typically an anesthetic drug, in subanesthetic doses to induce profound psychedelic experiences. The research primarily focuses on its application in treating alcoholism. A controlled clinical trial indicated a significant improvement in treating alcoholism using KPT, with 65.8% of patients achieving over one year of total abstinence, a substantial increase compared to the conventional treatment group. The study also explores the psychological mechanisms underlying KPT, revealing positive transformations in personality profiles, self-concept, emotional attitudes, life values, and spiritual development, all favoring sober living. Furthermore, the research highlights the biochemical and neurophysiological impacts of KPT, such as alterations in neurotransmitter metabolism and increased theta activity in the brain, providing insightful data into the complex interplay between pharmacological action and therapeutic efficacy.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy
Research
Ten-Year Review of Ketamine Psychedelic Therapy (KPT) for Alcoholism Treatment
This comprehensive review, published in the Journal of Psychoactive Drugs, encapsulates a decade of research on Ketamine Psychedelic Therapy (KPT). The study delves into the use of ketamine, typically an anesthetic drug, in subanesthetic doses to induce profound psychedelic experiences. The research primarily focuses on its application in treating alcoholism. A controlled clinical trial indicated a significant improvement in treating alcoholism using KPT, with 65.8% of patients achieving over one year of total abstinence, a substantial increase compared to the conventional treatment group. The study also explores the psychological mechanisms underlying KPT, revealing positive transformations in personality profiles, self-concept, emotional attitudes, life values, and spiritual development, all favoring sober living. Furthermore, the research highlights the biochemical and neurophysiological impacts of KPT, such as alterations in neurotransmitter metabolism and increased theta activity in the brain, providing insightful data into the complex interplay between pharmacological action and therapeutic efficacy.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy